EBSCO Health

EBSCO Health is a leading provider of clinical decision support solutions, healthcare business intelligence, medical journals...
Related Video:

Introducing the New DynaMed Mobile App

“I think I was the 5th install this morning!!! Love the ease of installing and explaining to our patrons! EBSCO/DynaMed got it right!”

Watch the video now »

PEMSoft is a great product, always has been. I wouldn’t hesitate to recommend it. It covers all pediatric conditions from minor to major, and it is an intuitive and logical tool for accessing information.
Dr. Chris May
Read More »

Recent News

DynaMed Introduces a New and Improved Mobile App

Users Can Easily Access Evidence-Based Content Anywhere with New App

Read More »

Introducing Nursing Reference Center Plus

New content including videos, images, nursing care plans, nursing leadership topics, and risk management topics.

Learn more about Nursing Reference Center Plus

See what KLAS has to say

DynaMed rated highest in both Clinical Decision Support 2011: Understanding the Impact and Clinical Decision Support 2013: Sizing up the competition by KLAS, outscoring every competitor—including UpToDate®. Nursing Reference Center rated highest in the nurse reference product category in the 2013 report as well. Read more about KLAS

Make it easy to access all of your library resources from one search box with EDS Discovery Health.

Meet the Clinical Leaders of EBSCO Health

Kevin Loughlin, MD, MBA, MA(Hon)
Deputy Editor, DynaMed

Kevin Loughlin, MD, MBA, MA(Hon) is Deputy Editor of Oncology and Hematology at DynaMed.  He is senior surgeon and a staff urologist at Brigham and Women’s Hospital, Harvard University Health Services, and Dana Farber Cancer Institute.  He is also the director of urologic research at Brigham and Women’s Hospital.  Dr. Loughlin is the program director for the Harvard Longwood Urology Residency Program and a trustee of the American Board of Urology.  He is on multiple journal editorial boards and has substantial research and leadership experience in urologic oncology.  He is board certified from the American Board of Urology.  Dr. Loughlin graduated from New York Medical College, with an MBA from Boston University, and completed his residency at Cornell Medical Center and the Harvard Program in Urology.

Read about our other clinical leaders »